The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated overall survival (OS) and exploratory analysis from the randomized, phase II EVAN study of erlotinib (E) versus vinorelbine plus cisplatin (NP) as adjuvant therapy in Chinese patients with stage IIIA EGFR+ NSCLC.
 
Dongsheng Yue
No Relationships to Disclose
 
Shi-Dong Xu
No Relationships to Disclose
 
Qun Wang
No Relationships to Disclose
 
Xiaofei Li
No Relationships to Disclose
 
Yi Shen
No Relationships to Disclose
 
Heng Zhao
No Relationships to Disclose
 
Chun Chen
No Relationships to Disclose
 
Weimin Mao
No Relationships to Disclose
 
Wei Liu
No Relationships to Disclose
 
Junfeng Liu
No Relationships to Disclose
 
Lan-Jun Zhang
No Relationships to Disclose
 
Haitao Ma
No Relationships to Disclose
 
Qiang Li
No Relationships to Disclose
 
Yue Yang
No Relationships to Disclose
 
Yongyu Liu
No Relationships to Disclose
 
Haiquan Chen
No Relationships to Disclose
 
Zhenfa Zhang
No Relationships to Disclose
 
Bin Zhang
No Relationships to Disclose
 
Fuyu Gong
No Relationships to Disclose
 
Changli Wang
No Relationships to Disclose